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We disprove that living cells stabilize ascorbate by the activity of a trans plasma membrane s midehydroascorbate eductase. The two processes 
show different specificities for both substrate and inhibitor. Not only cells but also cell-conditioned buffers tabilize ascorbate aslong as compounds 
with molecular weights above 10 kDa are not removed. The effect is most probably due to chelation of traces of transition metals. 
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1. INTRODUCTION 
Ascorbic acid is rapidly oxidized in neutral aqueous 
solutions through catalytic effects of transition metals 
[1-3], but it is relatively stable in biological fluids like 
plasma, serum or urine [4,5]. In blood plasma, ascor- 
bate is protected from oxidation by the complexation of 
the transition metals, i.e. iron and copper, by transferrin 
and caeruloplasmin, but also by albumin [3]. 
However, when traces of free iron or copper are pres- 
ent (iron overload and protein-free or low-protein fluids 
like vitreous humour or in vitro cell culture media), 
tissues or cells must prevent the loss of extracellular 
vitamin C by themselves to avoid severe oxidative stress 
reactions like lipid peroxidation [6-8]. DHA/ascorbate 
cycling mechanisms regenerating the reduced from the 
oxidized form have been described [9-13]. 
When living cells are added to protein free buffers, 
ascorbic acid is stabilized. This stabilization has been 
ascribed to the activity of a monodehydroascorbate re- 
ductase, an enzyme located in the plasma membrane 
which reduces the first oxidation product of ascorbic 
acid, the ascorbate free radical [14]. The efficiency of the 
stabilization has even been used as a quantitative meas- 
ure for the enzyme activity [15]. Such conclusions are 
overdrawn because the stabilization of ascorbate ob- 
served in the presence of cells can be explained in other 
ways. In this study we clearly distinguish between the 
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Abbreviations: BSO, buthionine sulfoximine; DHA, dehydroascorbic 
acid; GSH, reduced glutathione; HPLC, high-pressure liquid chroma- 
tography; TBSG, glucose-containing Tris-buffered saline. 
monodehydroascorbate reductase activity and the sta- 
bilization of ascorbic acid. 
2. MATERIALS AND METHODS 
DHA was obtained from Fluka (Buchs, Switzerland), BSO from 
Sigma. 
K-562 cells were grown in RPMI 1640 medium containing 2 mM 
glutamine, 100 U/ml penicillin/streptomycin and 10% fetal calf serum. 
Logarithmic growth was maintained by two weekly passages. 
Glutathione depletion was achieved by overnight incubation with 
180 mM buthionine sulfoximine (BSO) [16] and verified by GSH- 
determination with the enzyme cycling assay [17]. This treatment de- 
creased the GSH-content of the cells to less than 3% (results not 
shown). 
The stability of the generation, respectively, of ascorbic acid was 
determined in TBSG (140 mM NaC1, 20 mM Tris, 5 mM glucose, pH 
7.4) by HPLC with electrochemical detection [18]. 
Conditioned buffer was obtained by keeping 3 million cells (if not 
otherwise stated) in 1.5 ml of TBSG for one hour. During this time, 
no loss of viability could be observed by Trypan blue staining. The 
cells were then removed by centrifugation. 
Low and high molecular mass components of the buffer were sepa- 
rated by centrifugal filtration through a 10 kDa cut-off Millipore 
Ultrafree-CL membrane. 
3. RESULTS AND DISCUSSION 
In TBSG 5-50 ~tM ascorbate was rapidly degraded 
by autooxidation and subsequent degradation of DHA, 
as frequently described. 
With a starting concentration of 5 ¢tM, ascorbate 
became undetectable within 4 h (Fig. 1). 50/ IM ascor- 
bate completely disappeared within 10 h. This degrada- 
tion was inhibited by 50 / tM desferrioxamine, which 
confirms the importance of the presence of traces of 
iron for ascorbate autooxidation. The presence of 3 
million K-562 cells slowed down the degradation process. 
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Fig. 1. Disappearance of ascorbate in TBSG-buffer in the absence (o) 
and in the presence of50 #M desferrioxamine (~,), 3 million K562 cells 
(o), cells together with 1 mM thenoyltrifluoro-acetone (zx) and gluta- 
thione-depleted cells (*), starting from 5 ¢tM ascorbate (100%). 
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Fig. 2. Stability of isoascorbate in TBSG-buffer in the presence (•) or 
in the absence (o) of 3 million K562 cells. 
1 mM thenoyltrifluoroacetone, an inhibitor of the mon- 
odehydroascorbate reductase [19], had no effect on this 
stabilization. Cells depleted of intracellular glutathione 
by overnight incubation with 180#m BSO were as effec- 
tive as control cells (Fig. 1). 
With isoascorbate, the o-isomer of L-ascorbate, a
very similar effect was found (Fig. 2). Isoascorbate is
not transported into the cells by the ascorbate-specific 
mechanisms [13] and it is not a substrate for the mon- 
odehydroascorbate reductase ([20], Schweinzer, E. and 
Goldenberg, H., submitted). 
When the cells were removed by centrifugation after 
1 h and 5 /.tm ascorbate was added subsequently, it
remained stable for a prolonged time. 78% was still 
present after 5 h and 66% after 15 h (Fig. 3). 
One reason for this stabilization could have been 
complete removal of iron by cellular uptake. In this case 
addition of fresh TBSG, again containing traces of iron, 
should lead to enhanced ascorbate degradation. This 
was not the case. Only addition of 1 #M FeSO4 was able 
to reinitiate degradation of ascorbate (Fig. 3). 
The stabilization of ascorbate was inhibited by 20 #M 
p-hydroxy-mercuribenzoate,  sulfhydryl reagent. This 
may be taken as evidence for reducing thiols as stabiliz- 
ing factor(s) (Fig. 3). Two experimental findings argue 
against his assumption: first, the effect was very long- 
lasting and there was no sign of exhaustive consumption 
of putative reducing equivalents (Fig. 3); second, in con- 
trast to the cells themselves, the conditioned buffer was 
not able to generate ascorbate from DHA or from a 
mixture of both forms, i.e. a system with a maximal 
supply of monodehydroascorbate (Fig. 4). As already 
could be expected from the experiments with the cells, 
glutathione depletion had no effect on TBSG condition- 
ing (not shown). 
To obtain more information on the nature of the 
stabilizing factor(s), the cell-conditioned buffer was de- 
pleted of components with molecular mass higher than 
l0 kDa by ultrafiltration. This ultrafiltrate was not able 
to stabilize ascorbate anymore (Fig. 3). The conditioned 
buffer contained 0.2-1 mg/ml protein. When the cells 
were homogenized and a similar amount of protein was 
added to fresh buffer as that found in conditioned 
buffer after incubation with the cells for one hour, the 
stabilizing effect could be completely reproduced. 0.6 
mg/ml of bovine serum albumin was equally effective 
(not shown). 
The conclusions from these experimental findings 
are: Monodehydroascorbate reductase activity cannot 
be assayed as stabilization of ascorbic acid. Both proc- 
esses show different substrate and inhibitor specificities. 
Cells can stabilize ascorbic acid by releasing proteins 
which make transition metals uneffective in catalyzing 
its autoxidation [1,3,7,8]. This does not exclude the pos- 
sible function of reducing activities of the cells for mon- 
odehydroascorbate or DHA in regenerating ascorbate 
oxidized by oxygen radicals, oxidized tocopherol or 
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Fig. 3. Effect of buffer conditioning ofTBSG by 3 million K562 cells 
for 1 h on the stability of ascorbate added subsequently (e) and 
addition of unconditioned fresh buffer (*), 1/.tM FeSO4 (~,) and 20 ¢tM 
p-hydroxybutyrate (o) to it. (*): ascorbate concentration in an ultrafil- 
trate from conditioned buffer obtained by a 10 kDa cut-offmembrane. 
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Fig. 4. Ascorbic acid generation from 50 ~MDHA in conditioned 
TBSG alone(*)or inthe p~sence of 3 million cells(e). 
o ther  oxidat ive stress factors. However ,  exper imenta l  
setups have to be chosen careful ly to d iscr iminate be- 
tween the three effects. 
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